Citation Impact
Citing Papers
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Selective inhibition of bleomycin-induced G2 cell cycle checkpoint by simaomicin α
2004 StandoutNobel
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
2006 Standout
Mechanism Targeted Discovery of Antitumor Marine Natural Products
2004
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
1998 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
The effect of a self‐assembling peptide nanofiber scaffold (peptide) when used as a wound dressing for the treatment of deep second degree burns in rats
2008
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Chitosan-based hydrogels for controlled, localized drug delivery
2009 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Marine natural products
1990 Standout
Determination of the transcript profile of human endometrium
2003
Inhibitors of the Cip/Kip Family
1998
Cyclins and Cyclin–Dependent Kinases: Comparative Study of Hepatocellular Carcinoma Versus Cirrhosis
2003
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
2006
Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones
2006
Adipose-Derived Stem and Progenitor Cells as Fillers in Plastic and Reconstructive Surgery
2006
Sequential Dephosphorylation of p34 on Thr-14 and Tyr-15 at the Prophase/Metaphase Transition
1996
HPK1 competes with ADAP for SLP‐76 binding and via Rap1 negatively affects T‐cell adhesion
2010 StandoutNobel
Regulation of the G2/M transition by p53
2001 Standout
The Hallmarks of Cancer
2000 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.
2004
Functions of natural killer cells
2008 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Roadmap to embryo implantation: clues from mouse models
2006 Standout
Bridging the Gap: Modulatory Roles of the Grb2-Family Adaptor, Gads, in Cellular and Allergic Immune Responses
2019
Controlled Release of Endothelial Cell Growth Factor from Chitosan-Albumin Microspheres for Localized Angiogenesis: In Vitro and in Vivo Studies
1996
Malignant Gliomas in Adults
2008 Standout
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
1996
Protein kinases — the major drug targets of the twenty-first century?
2002 Standout
SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond
2006
Dnacin A1 and dnacin B1 are antitumor antibiotics that inhibit cdc25B phosphatase activity
1994
The Diels-Alder Reaction in Total Synthesis
2002 Standout
Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and in vivo
2001
Pre-eclampsia
2010 Standout
The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
2000
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
1999 Standout
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
1997
DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts
2000 StandoutNobel
Primary brain tumours in adults
2012 Standout
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
2007 Standout
Low molecular weight angiogenesis factors
1991
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone
2005
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals
1998
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
The LAT Story: A Tale of Cooperativity, Coordination, and Choreography
2010
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
Influences of Centrifugation on Cells and Tissues in Liposuction Aspirates: Optimized Centrifugation for Lipotransfer and Cell Isolation
2008
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
1994
Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5
1997
Extensive In Vivo Angiogenesis Following Controlled Release of Human Vascular Endothelial Cell Growth Factor: Implications for Tissue Engineering and Wound Healing
2001
Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis
2005
Both cyclin A and cyclin E have S-phase promoting (SPF) activity in Xenopus egg extracts
1996 StandoutNobel
Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
2001
p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells
1998
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
1999 Standout
A Concise Total Synthesis of Dysidiolide through Application of a Dioxolenium-Mediated Diels−Alder Reaction
1998
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Adipose-Derived Stem Cells for Regenerative Medicine
2007 Standout
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.
1995
Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase
1997 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
Compound library development guided by protein structure similarity clustering and natural product structure
2004
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Chemistry and Biology of the Tetrahydroisoquinoline Antitumor Antibiotics
2002 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
AMP-Activated Kinase Regulates Cytoplasmic HuR
2002
Short Linear Motifs: Ubiquitous and Functionally Diverse Protein Interaction Modules Directing Cell Regulation
2014
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
The NS5A/NS5 Proteins of Viruses from Three Genera of the Family Flaviviridae Are Phosphorylated by Associated Serine/Threonine Kinases
1998 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
The selectivity of protein kinase inhibitors: a further update
2007 Standout
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
A role for transcriptional repression of p21 CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest
2000
The ADAP/SKAP55 Signaling Module Regulates T-Cell Receptor-Mediated Integrin Activation through Plasma Membrane Targeting of Rap1
2006
Malignant glioma: genetics and biology of a grave matter
2001
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
T Cell Activation
2009 Standout
Angiogenesis.
1992 Standout
Works of Dvora Beach being referenced
Sequential phosphorylation of SLP‐76 at tyrosine 173 is required for activation of T and mast cells
2011
Modulation of TCR responsiveness by the Grb2-family adaptor, Gads
2014
Serum-free cell culture medium induces acceleration of wound healing in guinea-pigs
1995
Enhancing the Survival of Aspirated Human Fat Injected into Nude Mice
1998
Uterine angiogenic factor induces vascularization of collagen sponges in guinea-pigs
1989
Novel Hyperactive Mitogen to Endothelial Cells: Human Decidual NKG5
1999
p21 Is a Component of Active Cell Cycle Kinases
1994
Dual Role of SLP-76 in Mediating T Cell Receptor-induced Activation of Phospholipase C-γ1
2006
An Integrated Approach for Increasing the Survival of Autologous Fat Grafts in the Treatment of Contour Defects
1999
Effect of decidua angiogenic factors on experimental dermis allografts
1989
T Cell Receptor-induced Activation of Phospholipase C-γ1 Depends on a Sequence-independent Function of the P-I Region of SLP-76
2004
Dimerization of the adaptor Gads facilitates antigen receptor signaling by promoting the cooperative binding of Gads to the adaptor LAT
2017
Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.
1992
Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes
1994
SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK
2007
An Integrated Approach for Increasing the Survival of Autologous Fat Grafts in the Treatment of Contour Defects
1999